Methasterone (Superdrol)
Also known as: Superdrol, Methasteron, Methyldrostanolone, Methyl-Drostanolone, SD
Former 'designer supplement' sold openly until it was banned — a potent oral compound with documented cases of severe liver damage, including at conventional doses.
Substance family
Derived from dihydrotestosterone. They do not convert to estradiol, so no water retention — but also no estrogen of their own. Finasteride is useless against their hair loss, because they are already past the step it blocks. Hardest on the lipid profile.
Effects on
Which outcomes this substance acts on — descriptive, not a recommendation.
Strain profile
Where this substance is most likely to hit — a rough orientation, individually dependent on dose, duration and predisposition.
Dosing & protocols by goal
Rough orientation ranges as reported in harm-reduction literature — not an individual treatment plan. Doses are individual and open-ended; frequency depends on the ester or half-life.
Not medically indicated
MedicalDose
—
Frequency
—
Cycle length
—
Never developed as a medicine. Was marketed as a dietary supplement in the US until 2012, without approval or safety testing.
Short mass phase — Advanced
AdvancedDose
10–20 mg / day
Frequency
Split into 2 doses
Cycle length
3–4 weeks
The very short duration is dictated by liver toxicity. Cases of liver damage are documented in this dose range, not only above it.
Higher doses
AdvancedDose
> 20 mg / day
Frequency
Varies
Cycle length
—
The risk of serious liver damage rises sharply. Documented case reports involve doses in this region and durations beyond four weeks.
Side effect & countermeasure
Typical problems and what you can do to reduce harm — at a glance. Does not replace medical monitoring.
Problem
Severe liver toxicity with documented cases of liver failure
Countermeasure
This is the defining risk of the substance. Case reports of cholestaticcholestaticBile backing up in the liver because its flow is obstructed — the specific liver injury oral steroids cause. jaundice and liver failure exist at conventional doses. Check ALT, AST, GGT and bilirubin before, during and after; avoid alcohol entirely; never combine with other orals; do not exceed 3–4 weeks. Yellow skin or eyes, dark urine, itching or persistent upper abdominal pain: stop immediately and seek medical attention. TUDCA at 500–1000 mg daily addresses the cholestatic mechanism directly; NAC supports the antioxidant system alongside it.
Problem
Severe drop in HDL — among the most pronounced of any oral compound
Countermeasure
Cardio, omega-3 and citrus bergamot as the base; with strongly deteriorated values, ezetimibe or pitavastatin under medical guidance. Measure a lipid baseline before starting. If a statin is started, CoQ10 belongs alongside it — statins deplete it through the same pathway.
Problem
Markedly elevated blood pressure
Countermeasure
Measure at home daily. Control salt and water balance, keep cardio in the plan; medically, telmisartan, amlodipine or lisinopril, and low-dose tadalafil.
Problem
Pronounced lethargy and lower back pumps
Countermeasure
Both are characteristic and often limit training more than expected. Adequate hydration and electrolytes help with the pumps; persistent lethargy indicates the dose is too high.
Problem
Estradiol falls too low
Countermeasure
Methasterone does not aromatizearomatizeThe body converting testosterone into estrogen via the aromatase enzyme.. Without a testosterone base, estradiolestradiolThe main estrogen — needed in men too, and damaging in both directions when out of range. drops along with natural testosterone — do not add an aromatase inhibitoraromatase inhibitorA drug that blocks the conversion of testosterone to estradiol. on top.
Problem
Suppression of natural testosterone production
Countermeasure
Pronounced despite the short duration. A post-cycle plan belongs in place before starting; plan with the PCTPCTThe protocol after a cycle intended to restart the body's own testosterone production. timeline.
Problem
Assumption of harmlessness from its supplement history
Countermeasure
That it was once sold legally in shops says nothing about its safety — it was withdrawn precisely because of liver damage reports. Treat it as what it is: a potent oral steroid with an above-average risk profile.
Overview
Methasterone, sold under the name Superdrol, has an unusual history. It was marketed in the United States as a dietary supplement in the 2000s — legally available, sold in shops, without approval or safety testing, because it fell through a gap in the regulation of prohormones at the time.
That gap was closed in 2012, after case reports of severe liver damage accumulated. The substance has been classified as an anabolic steroid ever since. Its history nonetheless still shapes its perception: the fact that it was once freely available suggests a harmlessness that was never justified.
Mechanism of Action
Methasterone is drostanolone with an added methyl group at position 17 — hence the alternative name methyldrostanolone. That single modification makes the injectable drostanolone orally available and, at the same time, considerably more liver-toxic.
The substance does not aromatize and binds strongly to the androgen receptor. Its anabolic effect is pronounced, which explains its popularity despite the risk profile.
The liver toxicity is where methasterone differs from other 17-alpha-alkylated compounds, and not merely in degree. The documented case reports describe cholestatic jaundice — a build-up of bile in the liver — with jaundice, severe itching and, in some cases, liver failure. Crucially, these cases did not all involve extreme doses; a considerable proportion occurred within the range commonly used.
Typical Context
Methasterone is used in short mass phases, over three to four weeks, at ten to twenty milligrams a day and generally alongside a testosterone base. The very short duration is not caution but a direct consequence of the liver risk.
Two side effects shape practical use more than the numbers suggest. Lethargy is common and often noticeable enough to work against the training the substance is meant to support. Lower back pumps during exercise can become severe enough to interrupt sets. Both are characteristic and dose-dependent.
The substance's supplement past deserves a mention because it still influences how people handle it. Anyone assuming that a compound once sold openly in shops must be comparatively harmless has the causality backwards: it was withdrawn precisely because it was not.
Side Effects & Risks
- Severe liver toxicity with documented cases of cholestatic jaundice and liver failure
- Severe drop in HDL, rise in LDL
- Markedly elevated blood pressure
- Pronounced lethargy
- Severe lower back pumps during training
- Estradiol too low without a testosterone base
- Suppression of natural testosterone production
- Acne, accelerated hair loss with a genetic predisposition
Blood Work & Monitoring
- Liver values (ALT, AST, GGT, bilirubin) — baseline, during and after; non-negotiable with this substance
- Lipid profile (LDL, HDL, triglycerides) — baseline and during use
- Blood pressure — measured at home, daily
- Total/free testosterone — to assess suppression
- Estradiol (sensitive) — watch for levels that are too low
- Hematocrit & hemoglobin
Harm-Reduction Notes
- Liver values are the deciding factor; measure a baseline and check during use, not only afterwards
- Do not exceed 3–4 weeks under any circumstances
- Avoid alcohol entirely; never combine with other oral compounds
- Jaundice, dark urine, itching or persistent upper abdominal pain: stop immediately and seek medical attention
- Do not push through lethargy — it indicates the dose is too high
- Its former availability as a supplement is not an indication of safety
- A post-cycle plan is necessary despite the short duration
Legal status by region
Regulation differs considerably between jurisdictions and changes over time. This is a rough orientation, not legal advice — check the rules that apply where you are.
| Region | Regulatory status |
|---|---|
| United States | Schedule III controlled substanceNo approved human indication; distribution is a federal offence. |
| EU / UK | Not approved for human useSome compounds exist only as veterinary products or not at all. |
| Canada / Australia | Controlled substanceNo human indication. |
| Parts of Asia & Latin America | Grey market, largely unregulatedAvailability does not imply pharmaceutical quality — underground-lab product dominates. |
| Competitive sport | Prohibited at all timesListed by WADA. |